We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Fluorescent Technique Allows Quantitative Measurement of Cell Membrane Lipids

By LabMedica International staff writers
Posted on 25 Oct 2011
A recent paper described the development of a method for the in situ quantification of cell membrane lipids, which are important signaling elements that have been linked to certain disease states, inflammation, and the immune response system.

The current study is among the first to describe a quantitative method for measuring lipid concentration in the membrane of a living cell. More...
To accomplish this task investigators at the University of Illinois (Chicago, USA) used a new chemical method to label proteins with an environmentally sensitive fluorophore. A prototype sensor for the lipid phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) - a key signaling lipid in diverse cellular processes - was generated by covalently attaching a single 2-dimethylamino-6-acyl-naphthalene group to the N-terminal alpha-helix of the engineered epsin1 ENTH domain, a protein that selectively binds PtdIns(4,5)P2.

Results reported in the October 9, 2011, online edition of the journal Nature Chemistry revealed that tracking the signal generated by binding of the fluorescent protein to this key signaling lipid allowed robust and sensitive in situ quantitative imaging in mammalian cells that provided new insight into the dynamics and fluctuation of the lipid within the microenvironment of the cell membrane.

“Lipid molecules on cell membranes can act as switches that turn on or off protein-protein interactions affecting all cellular processes, including those associated with disease," said senior author Dr. Wonhwa Cho, professor of chemistry at the University of Illinois. “While the exact mechanism is still unknown, our hypothesis is that lipid molecules serve sort of like a sliding switch. It is not just the presence of lipid, but the number of lipid molecules that are important for turning on and off biological activity.”

“We had to engineer the protein in such a way to make it very stable, behave well, and specifically recognize a particular lipid,” said Dr. Cho. “We would like to be able to measure multiple lipids, simultaneously. It would give us a snapshot of all the processes being regulated by the different lipids inside a cell.”

Related Links:
University of Illinois


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.